Los Angeles Capital Management LLC Sells 38,742 Shares of LifeMD, Inc. $LFMD

Los Angeles Capital Management LLC trimmed its position in shares of LifeMD, Inc. (NASDAQ:LFMD) by 29.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 91,117 shares of the company’s stock after selling 38,742 shares during the period. Los Angeles Capital Management LLC owned approximately 0.20% of LifeMD worth $1,241,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Y Intercept Hong Kong Ltd acquired a new position in LifeMD during the 2nd quarter worth approximately $818,000. Nuveen LLC bought a new position in shares of LifeMD during the first quarter worth about $1,545,000. Wealth Enhancement Advisory Services LLC acquired a new position in shares of LifeMD in the 2nd quarter worth approximately $193,000. Royce & Associates LP grew its holdings in LifeMD by 3.5% during the 1st quarter. Royce & Associates LP now owns 1,155,231 shares of the company’s stock worth $6,284,000 after acquiring an additional 39,240 shares during the period. Finally, Jump Financial LLC increased its holdings in LifeMD by 69.9% in the first quarter. Jump Financial LLC now owns 168,881 shares of the company’s stock worth $919,000 after purchasing an additional 69,502 shares in the last quarter. Institutional investors own 35.52% of the company’s stock.

LifeMD Trading Up 0.2%

LFMD stock opened at $5.07 on Thursday. The company has a debt-to-equity ratio of 9.21, a quick ratio of 0.72 and a current ratio of 0.77. The company has a market capitalization of $240.40 million, a PE ratio of -24.14 and a beta of 1.57. The company’s 50 day moving average price is $6.14 and its two-hundred day moving average price is $8.75. LifeMD, Inc. has a one year low of $4.13 and a one year high of $15.84.

Insider Buying and Selling at LifeMD

In related news, insider Nicholas P. Alvarez sold 75,000 shares of the stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $5.92, for a total transaction of $444,000.00. Following the completion of the sale, the insider directly owned 605,000 shares in the company, valued at $3,581,600. This represents a 11.03% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 18.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on LFMD. Zacks Research raised LifeMD from a “strong sell” rating to a “hold” rating in a research report on Friday, September 5th. Wall Street Zen downgraded shares of LifeMD from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. KeyCorp reduced their price target on shares of LifeMD from $14.00 to $12.00 and set an “overweight” rating for the company in a research report on Wednesday, August 6th. HC Wainwright decreased their target price on LifeMD from $14.00 to $13.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Finally, Weiss Ratings restated a “sell (d-)” rating on shares of LifeMD in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, LifeMD presently has a consensus rating of “Moderate Buy” and a consensus price target of $13.17.

LifeMD Company Profile

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.